U.S. FDA approves Pfizer’s COVID-19 booster vaccine for kids ages 5-11 – National | Globalnews.ca

The U.S. Meals and Drug Administration (FDA) licensed Tuesday single booster doses of Pfizer-BioNTech’s COVID-19 vaccine for youngsters ages 5 to 11.

Kids inside that age bracket will be capable of get a booster dose at the least 5 months after their first two doses of the Pfizer vaccine after the FDA amended its emergency use authorization for it.

Learn extra:

Pfizer booster for kids 5 to 11 helps protect against Omicron variant, company says

“Whereas it has largely been the case that COVID-19 tends to be much less extreme in kids than adults, the omicron wave has seen extra youngsters getting sick with the illness and being hospitalized, and kids might also expertise long run results, even following initially gentle illness,” FDA commissioner Robert M. Califf mentioned in an announcement.

“The FDA is authorizing the usage of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine for youngsters 5 via 11 years of age to supply continued safety towards COVID-19.”

Story continues under commercial

Califf mentioned vaccination is the best technique to stop COVID-19 and probably extreme penalties, together with hospitalization and loss of life.

The FDA beforehand permitted a booster dose for people 12 to fifteen years previous in January, whereas the primary two doses for these 5 to 11 have been permitted in October 2021.

Click to play video: 'U.S. FDA has now approved Pfizer’s COVID-19 booster shot for 12- to 15-year-olds'

U.S. FDA has now permitted Pfizer’s COVID-19 booster shot for 12- to 15-year-olds

U.S. FDA has now permitted Pfizer’s COVID-19 booster shot for 12- to 15-year-olds – Jan 3, 2022

The company has decided that the advantages of a booster dose for the younger age class outweigh the potential dangers.

The FDA got here to its conclusion on the booster’s effectiveness for youths after finding out antibody responses in 67 individuals who acquired a booster dose seven to 9 months after the primary two-dose collection.

“The antibody degree towards the SARS-CoV-2 virus one month after the booster dose was elevated in comparison with earlier than the booster dose,” the FDA mentioned in an announcement.

Story continues under commercial

To find out the security of the booster dose on kids, the FDA did a examine of about 400 youngsters who acquired the dose 5 to 9 months after the primary collection. That examine discovered the most typical negative effects have been ache, redness and swelling on the injection web site, in addition to fatigue, headache, muscle or joint ache, and chills and fever.

Learn extra:

Pfizer seeks U.S. approval of COVID-19 booster for children aged 5-11

It’s unclear what number of dad and mom of kids within the age group will go for a 3rd dose, although, as solely 28.8 per cent of children 5 to 11 are absolutely vaccinated within the U.S., in line with the U.S. Facilities for Illness Management and Prevention.

Kids below 5 should not but eligible for a COVID-19 vaccine within the U.S.

© 2022 International Information, a division of Corus Leisure Inc.

Leave a Comment